GVOKE

Serial Number 88011935
Registration 6019623
700

Registration Progress

Application Filed
Jun 22, 2018
Under Examination
Jan 15, 2019
Approved for Publication
Nov 20, 2018
Published for Opposition
Nov 20, 2018
Registered
Mar 24, 2020

Attorney Assistance

Section 8 (6-Year) Declaration Due (Based on registration date 2020-03-24)
Due: Mar 24, 2026 234 days

Trademark Image

GVOKE

Basic Information

Serial Number
88011935
Registration Number
6019623
Filing Date
June 22, 2018
Registration Date
March 24, 2020
Published for Opposition
November 20, 2018
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 24, 2020
Registration
Registered
Classes
005

Rights Holder

Xeris Pharmaceuticals, Inc.

03
Address
180 N LaSalle Street, Suite 1810
Chicago, IL 60601

Ownership History

Xeris Pharmaceuticals, Inc.

Original Applicant
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Owner at Publication
03
Chicago, IL

Xeris Pharmaceuticals, Inc.

Original Registrant
03
Chicago, IL

Legal Representation

Attorney
Tracy-Gene G. Durkin

USPTO Deadlines

Next Deadline
234 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-03-24)
Due Date
March 24, 2026
Grace Period Ends
September 24, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

34 events
Date Code Type Description Documents
Mar 24, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jun 23, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 19, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
May 22, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
May 22, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 22, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
May 22, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
May 22, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Mar 24, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 20, 2020 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Feb 19, 2020 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 19, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 18, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 18, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 18, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 2, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 2, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 2, 2020 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Dec 9, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 9, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 2, 2019 IUAF S USE AMENDMENT FILED Loading...
Dec 2, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jun 25, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 21, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 21, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 21, 2019 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 15, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 20, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 20, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 31, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 11, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 11, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 29, 2018 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 26, 2018 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical products for the treatment of diabetes and metabolic diseases; medical apparatus, namely, a drug delivery device prefilled with pharmaceutical products for the treatment of diabetes and metabolic diseases; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of diabetes and metabolic diseases
First Use Anywhere: Nov 4, 2019
First Use in Commerce: Nov 4, 2019

Classification

International Classes
005